Search research articles
Contact Us
Filters
Showing results (761-770 of 876) with videos related to
Page
of 88
Sort By:
Antioxidants & Redox Signaling
|
March 26, 2013
Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses
Rupak Pathak, Snehalata A Pawar, Qiang Fu, et al.
Nature Chemical Biology
|
February 19, 2021
Optical control of fast and processive engineered myosins in vitro and in living cells
Paul V Ruijgrok, Rajarshi P Ghosh, Sasha Zemsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 13, 2019
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy
Edwin Jabbari, John Woodside, Manuela M X Tan, et al.
BMJ Open
|
July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK
Robert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
The British Journal of Dermatology
|
February 17, 2017
Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study
P Dani, N Patnaik, A Singh, et al.
IJTLD Open
|
March 18, 2026
Cervical lymph node TB: diagnostic yield and patient profile
F R Luba, P Ghosh, S Anwar, et al.
Human Brain Mapping
|
June 3, 2023
Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
David J Whiteside, Duncan Street, Alexander G Murley, et al.
Cancer Discovery
|
July 25, 2019
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver
Richard L Bennett, Aditya Bele, Eliza C Small, et al.
Cancer Discovery
|
September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer
Eun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Radiation Research
|
May 12, 2021
Celebrating 60 Years of Accomplishments of the Armed Forces Radiobiology Research Institute1
Balazs J Bene, William F Blakely, David M Burmeister, et al.
Page
of 88
Search research articles
Search
Showing results (761-770 of 876) with videos related to
Sort By:
Page
of 88
Antioxidants & Redox Signaling
|
March 26, 2013
Characterization of transgenic Gfrp knock-in mice: implications for tetrahydrobiopterin in modulation of normal tissue radiation responses
Rupak Pathak, Snehalata A Pawar, Qiang Fu, et al.
Nature Chemical Biology
|
February 19, 2021
Optical control of fast and processive engineered myosins in vitro and in living cells
Paul V Ruijgrok, Rajarshi P Ghosh, Sasha Zemsky, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 13, 2019
The genetic and clinico-pathological profile of early-onset progressive supranuclear palsy
Edwin Jabbari, John Woodside, Manuela M X Tan, et al.
BMJ Open
|
July 29, 2025
Noradrenaline for progressive supranuclear palsy syndromes (NORAPS): a randomised, double-blind, placebo-controlled, crossover Phase IIb clinical trial evaluating the efficacy and safety of oral atomoxetine for treating cognitive and behavioural changes in people with progressive supranuclear palsy syndromes in the UK
Robert Durcan, Hugo Paula, Boyd C P Ghosh, et al.
The British Journal of Dermatology
|
February 17, 2017
Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study
P Dani, N Patnaik, A Singh, et al.
IJTLD Open
|
March 18, 2026
Cervical lymph node TB: diagnostic yield and patient profile
F R Luba, P Ghosh, S Anwar, et al.
Human Brain Mapping
|
June 3, 2023
Network connectivity and structural correlates of survival in progressive supranuclear palsy and corticobasal syndrome
David J Whiteside, Duncan Street, Alexander G Murley, et al.
Cancer Discovery
|
July 25, 2019
A Mutation in Histone H2B Represents a New Class of Oncogenic Driver
Richard L Bennett, Aditya Bele, Eliza C Small, et al.
Cancer Discovery
|
September 4, 2014
L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer
Eun-Hee Shim, Carolina B Livi, Dinesh Rakheja, et al.
Radiation Research
|
May 12, 2021
Celebrating 60 Years of Accomplishments of the Armed Forces Radiobiology Research Institute1
Balazs J Bene, William F Blakely, David M Burmeister, et al.
Page
of 88